Abstract

Background

We recently found headache disorders to be highly prevalent among children (aged 6–11 years) and adolescents (aged 12–17) in Iran (gender- and age-adjusted 1-year prevalences: migraine 25.2%, tension-type headache 12.7%, undifferentiated headache [UdH] 22.1%, probable medication-overuse headache [pMOH] 1.1%, other headache on ≥ 15 days/month [H15+] 3.0%). Here we report on the headache-attributed burden, taking evidence from the same study.

Methods

In a cross-sectional survey, following the generic protocol for the global schools-based study led by the Global Campaign against Headache, we administered the child and adolescent versions of the Headache-Attributed Restriction, Disability, Social Handicap and Impaired Participation (HARDSHIP) structured questionnaire in 121 schools, purposively selected to reflect the country’s diversities. Pupils self-completed these in class, under supervision. Headache diagnostic questions were based on ICHD-3 criteria but for the inclusion of UdH (defined as mild headache with usual duration < 1 h). Burden enquiry was across multiple domains.

Results

The analysed sample (N = 3,244) included 1,308 (40.3%) children and 1,936 (59.7%) adolescents (1,531 [47.2%] male, 1,713 [52.8%] female). The non-participating proportion was 3.4%. Mean headache frequency was 3.9 days/4 weeks, and mean duration 1.8 h. Estimated mean proportion of time in ictal state was 1.1% (1.4% for migraine, 16.5% for pMOH). Symptomatic medication was consumed on a mean of 1.6 days/4 weeks. Lost school time averaged 0.4 days/4 weeks overall (2%, assuming a 5-day week), but was eleven-fold higher (4.3 days; 22%) for pMOH. For most headache types, days of reported limited activity were several-fold more than days lost from school (45% for pMOH, 25% for other H15+). Almost one in 12 parents (7.9%) missed work at least once in 4 weeks because of their son’s or daughter’s headache. Emotional impact and quality-of-life scores reflected these measures of burden.

Conclusions

Headache, common in children and adolescents in Iran, is associated with symptom burdens that may be onerous for some but not for most. However, there are substantial consequential burdens, particularly for the 1.1% with pMOH and the 3.0% with other H15+, who suffer educational disturbances and potentially major life impairments. These findings are of importance to educational and health policies in Iran.

Details

Title
The burdens attributable to primary headache disorders in children and adolescents in Iran: estimates from a schools-based study
Author
Togha, Mansoureh 1 ; Rafiee, Pegah 2 ; Haghdoost, Faraidoon 3 ; Rafie, Shahram 4 ; Paknejad, Seyed Mohammad Hasan 5 ; Amouian, Sepideh 6 ; Şaşmaz, Tayyar 7 ; Kale, Derya 7 ; Uluduz, Derya 8 ; Steiner, Timothy J. 9 

 Tehran University of Medical Sciences, Headache Department, Iranian Center of Neurological Researches, Institute of Neuroscience, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922); Sina Hospital, Tehran University of Medical Sciences, Neurology Ward, School of Medicine, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922) 
 National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, Tehran, Iran (GRID:grid.411600.2) 
 University of New South Wales (UNSW), The George Institute for Global Health, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432) 
 Ahvaz Jundishappur University of Medical Sciences, Department of Neurology, School of Medicine, Ahvaz, Iran (GRID:grid.411230.5) (ISNI:0000 0000 9296 6873) 
 Tehran University of Medical Sciences, Headache Department, Iranian Center of Neurological Researches, Institute of Neuroscience, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922) 
 Golestan University of Medical Sciences, Neonatal and Children’s Health Research Center, Gorgan, Iran (GRID:grid.411747.0) (ISNI:0000 0004 0418 0096); Golestan University of Medical Sciences, Pediatric Neurology Department, Faculty of Medicine, Gorgan, Iran (GRID:grid.411747.0) (ISNI:0000 0004 0418 0096) 
 Mersin University School of Medicine, Department of Public Health, Mersin, Turkey (GRID:grid.411691.a) (ISNI:0000 0001 0694 8546) 
 Istanbul University, Neurology Department, Cerrahpaşa School of Medicine, Istanbul, Turkey (GRID:grid.9601.e) (ISNI:0000 0001 2166 6619) 
 Norwegian University of Science and Technology, Department of Neuromedicine and Movement Science, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393); University of Copenhagen, Department of Neurology, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Imperial College London, Division of Brain Sciences, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
Pages
86
Publication year
2024
Publication date
Dec 2024
Publisher
Springer Nature B.V.
ISSN
11292369
e-ISSN
11292377
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3060206869
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.